In recent years, a number of drugs have emerged that have significant cardio-renal protective effects in patients with diabetes, and a typical example is sodium-glucose cotransporter 2 inhibitor (SGLT2i), glucagon-like peptide-1 receptor agonist (GLP-1RA), and nonsteroidal mineralocorticoid receptor antagonist, finerenone
Presented for research literature review only Alto W (1987)
I sin forskning har Malin Fex och hennes kollegor hittat en genvariant p en av receptorerna fr melatonin som gr att kroppens frmga att fristta insulin frsmras
Investigators commonly use this analog to dissect incretin-axis signaling in pancreatic islet preparations, hypothalamic appetite-regulation studies, and gastric motility models
Neuroinflammation Context: Used in research exploring oxidative stress, inflammatory signaling, and nervous-system protection pathways